LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial
Saved in:
Published in: | Annals of oncology Vol. 33; p. S1406 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
01-09-2022
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Author | van den Berg, J.H. Nuijen, B. Haanen, J.B.A.G. Donia, M. Foppen, M. Geukes Wilgenhof, S. Rohaan, M. Kessels, R. Nijenhuis, C. Beijnen, J.H. Svane, I-M. Granhøj, J. Stoltenborg Met, Ö. Jedema, I. Lalezari, F. van Zon, M. van Thienen, H.V. Borch, T.H. Noringriis, I. Mansfield van Akkooi, A.C.J. |
---|---|
Author_xml | – sequence: 1 givenname: J.B.A.G. surname: Haanen fullname: Haanen, J.B.A.G. – sequence: 2 givenname: M. surname: Rohaan fullname: Rohaan, M. – sequence: 3 givenname: T.H. surname: Borch fullname: Borch, T.H. – sequence: 4 givenname: J.H. surname: van den Berg fullname: van den Berg, J.H. – sequence: 5 givenname: Ö. surname: Met fullname: Met, Ö. – sequence: 6 givenname: M. Geukes surname: Foppen fullname: Foppen, M. Geukes – sequence: 7 givenname: J. Stoltenborg surname: Granhøj fullname: Granhøj, J. Stoltenborg – sequence: 8 givenname: B. surname: Nuijen fullname: Nuijen, B. – sequence: 9 givenname: C. surname: Nijenhuis fullname: Nijenhuis, C. – sequence: 10 givenname: J.H. surname: Beijnen fullname: Beijnen, J.H. – sequence: 11 givenname: I. surname: Jedema fullname: Jedema, I. – sequence: 12 givenname: M. surname: van Zon fullname: van Zon, M. – sequence: 13 givenname: I. Mansfield surname: Noringriis fullname: Noringriis, I. Mansfield – sequence: 14 givenname: R. surname: Kessels fullname: Kessels, R. – sequence: 15 givenname: S. surname: Wilgenhof fullname: Wilgenhof, S. – sequence: 16 givenname: H.V. surname: van Thienen fullname: van Thienen, H.V. – sequence: 17 givenname: F. surname: Lalezari fullname: Lalezari, F. – sequence: 18 givenname: A.C.J. surname: van Akkooi fullname: van Akkooi, A.C.J. – sequence: 19 givenname: M. surname: Donia fullname: Donia, M. – sequence: 20 givenname: I-M. surname: Svane fullname: Svane, I-M. |
BookMark | eNotkM1OwzAQhH0oEm3hDTjsESQSnDhNY26l4idSJCRUztHGcair2K5sp6g8CY9LqnKZ1Yy0O9pvRibGGknITULjhCb5wy5GM0YiTmmaxrSIKcsnZEp5yqLlgmWXZOb9jlKa85RPyW_1tGKwcRKDlibAtwpbCIO2LlKmU31wGJT5gv6o91srjkF6uN2U1R0cpPODB7VXvdKDxgY66wDbAxohW9CyR2M1PsKH9EMfPHTOakDQo1Fi7JLuHhya1mr1My7st-gllGUJwSnsr8hFh72X1_9zTj5fnjfrt6h6fy3XqyoSSZbm0bLBvJEipU2enz6SnAlMRZsgUkbbgiE2DOXouVyIxVIIzpuu40XW8VELNifZ-a5w1nsnu3rvlEZ3rBNan4jWu_pMtD4RrWlRj0TZHznZc_E |
CitedBy_id | crossref_primary_10_1016_j_ctrv_2022_102499 crossref_primary_10_3390_cancers15194814 crossref_primary_10_1024_1661_8157_a003972 crossref_primary_10_1186_s11658_024_00561_1 crossref_primary_10_3390_cancers15041106 crossref_primary_10_1007_s40257_023_00762_y crossref_primary_10_1136_jitc_2023_006947 crossref_primary_10_1007_s11864_023_01069_0 crossref_primary_10_1158_1541_7786_MCR_22_0898 crossref_primary_10_1186_s12943_023_01914_8 crossref_primary_10_1080_14712598_2023_2193290 crossref_primary_10_3389_fimmu_2022_1018962 crossref_primary_10_1016_j_intimp_2023_109882 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1016/j.annonc.2022.08.036 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 10_1016_j_annonc_2022_08_036 |
GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6J9 70D AAEDW AAJKP AAJQQ AAKAS AAKUH AALRI AAMVS AAOGV AAPNW AAUQX AAXUO AAYXX ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEYI ADHKW ADHZD ADJQC ADOCK ADRIX ADRTK ADVLN ADYVW ADZCM ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFETI AFIYH AFJKZ AFOFC AFSHK AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASPBG ATTQO AVWKF AXUDD AZFZN BAWUL BAYMD BGNMA BHONS BTRTY BVRKM BZKNY C1A CAG CDBKE CITATION CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 |
ID | FETCH-LOGICAL-c1426-7ba6bec20b666929e93ca2cd1aa030d83aab3aed1a9e5c57cc99bff984f9f9883 |
ISSN | 0923-7534 |
IngestDate | Fri Nov 22 00:04:09 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1426-7ba6bec20b666929e93ca2cd1aa030d83aab3aed1a9e5c57cc99bff984f9f9883 |
OpenAccessLink | https://doi.org/10.1016/j.annonc.2022.08.036 |
ParticipantIDs | crossref_primary_10_1016_j_annonc_2022_08_036 |
PublicationCentury | 2000 |
PublicationDate | 2022-09-00 |
PublicationDateYYYYMMDD | 2022-09-01 |
PublicationDate_xml | – month: 09 year: 2022 text: 2022-09-00 |
PublicationDecade | 2020 |
PublicationTitle | Annals of oncology |
PublicationYear | 2022 |
SSID | ssj0006929 |
Score | 2.4432194 |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | S1406 |
Title | LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ1Lj9MwEMet7iIhLoineMsHDqCQiMTOi1sLhRZ2uWyRuEVjJ9nNKo9quzksn4SPyziOk8CuEHvgErVua6Wen2zP5D9jQl6Cl_q-EOiWcBds7rrShjjgNqRqMRSB9LnKRl4dhV-_Rx-WfDmbmTPnxrb_amlsQ1urzNlrWHvoFBvwNdocr2h1vP6T3Q8Wc1Wy3MjHdZy1rZozG3svyq5Kbn1slRdoxkZe9GHXzfpAxQeURqPdWcW2KIuqrUBokaXRCVRZCXVTgVbR7dryfKfzU0ALE5XSUyOAK2DaVMUP_NH2BBdKa71eW90JIdPd8Fi9uanlb_H9FUDdp404C2fufHLGJ0MnoIO2h0PboulPtNo4q6FRJWbhpGotegHbZ_NZH-NA99iIuIZgpcdsdKz4dN5mbDLxHqGjGFy5JOjoxKkDdY3_xVHdd0Vb2RUVuP9YGQe9opHCnSa6l0T1kqjzO1mwR254OMl17vz6y7ALCGJP13ns79ykbXbawsv3MtkWTfY3mzvkdu-Y0Lkm6i6ZZfU9cvOwl17cJz8VWHQAiyqw6GWw6AQs-gqxek01VHSEiiJU1EBFDVTvaI8UVUhRoBOk3tARKNoBRREo2gH1gHz7uNy8X9n9sR62dHE_aIcCApw5vLcCXWccpSxmEjyZugC44qQRAxAMMnwfZ770QynjWOR5HPE8xmvEHpJ9HL7sEaEBz0WUBqEQEHE3iwD8KHJZCCzNUp77j4ltRjXZ6uotyd9s-eSa339Kbo24PiP752dt9pzs7dL2RUfDLz6NleI |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LBA3+Treatment+with+tumor-infiltrating+lymphocytes+%28TIL%29+versus+ipilimumab+for+advanced+melanoma%3A+Results+from+a+multicenter%2C+randomized+phase+III+trial&rft.jtitle=Annals+of+oncology&rft.au=Haanen%2C+J.B.A.G.&rft.au=Rohaan%2C+M.&rft.au=Borch%2C+T.H.&rft.au=van+den+Berg%2C+J.H.&rft.date=2022-09-01&rft.issn=0923-7534&rft.volume=33&rft.spage=S1406&rft_id=info:doi/10.1016%2Fj.annonc.2022.08.036&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_annonc_2022_08_036 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |